Cost analysis of therapy for patients with multiple sclerosis (MS) in Poland.

Journal Title: Pharmacological Reports - Year 2008, Vol 60, Issue 5

Abstract

Multiple sclerosis (MS) is a neurological disease of the central nervous system in which dissipated demyelination lesions develop. The currently available pharmacotherapy and rehabilitation for this disease aims to preserve the patients' physical abilities and prevent disease progression and nervous system damage. The study evaluated the direct and indirect costs associated with two different treatment regimens for multiple sclerosis diagnosed patients by comparing two groups of 60 subjects (Group A - patients receiving continuous interferon therapy (Betaferon) and steroids during relapses, and Group B - patients receiving steroid-only (Solu-Medrol, Metypred) treatment). The study was conducted over two years (2004-2005). The pharmacotherapy costs for MS patients were: PLN 4,555,360.68 (1,171,043.88euro) total for Group A and PLN 75,922.68 (19,517.40euro) per patient, and PLN 72,582.00 (18,658.61euro) total for Group B and PLN 1,209.70 (310.98euro) per patient. Total direct and indirect costs for Group A and Group B amounted to PLN 5,595,968.58 (1,438,552.33euro) and PLN 1,655,658.30 (425,619.10euro), respectively.

Authors and Affiliations

Arleta Matschay, Elzbieta Nowakowska, Hanka Hertmanowska, Krzysztof Kus, Anna Czubak

Keywords

Related Articles

Potentiation of neuronal insulin signaling and glucose uptake by resveratrol: the involvement of AMPK.

Resveratrol (RSV), a polyphenolic phytoestrogen, has been shown to activate the serine/threonine kinase 5'-adenosine monophosphate-activated protein kinase (AMPK) and to stimulate insulin signaling and glucose uptake in...

Comparison of the analgesic efficacy of preemptive and preventive tramadol after lumpectomy.

The aim of this study was to investigate the analgesic efficacy of tramadol administrated preemptively or preventively in the earlier period of lumpectomy. Four hundred American Society of Anesthesiologists (ASA) physica...

Prodrugs: A challenge for the drug development.

It is estimated that about 10% of the drugs approved worldwide can be classified as prodrugs. Prodrugs, which have no or poor biological activity, are chemically modified versions of a pharmacologically active agent, whi...

Neuroprotective effects of MTEP, a selective mGluR5 antagonists and neuropeptide Y on the kainate-induced toxicity in primary neuronal cultures.

The majority of studies on neuroprotection tested potentially protective compounds given before, simultaneously or shortly after damage. Such procedures are greatly different from the situation faced in clinical practice...

Exposure to ethanol and tobacco smoke in relation to level of PCNA antigen expression in pancreatic and hepatic rat cells.

Previous results proved that simultaneous effect of tobacco smoke constituents and alcohol consumption may change toxicity of these substances and have a greater effect on hepatic and pancreatic disease and cancer risk....

Download PDF file
  • EP ID EP134071
  • DOI -
  • Views 79
  • Downloads 0

How To Cite

Arleta Matschay, Elzbieta Nowakowska, Hanka Hertmanowska, Krzysztof Kus, Anna Czubak (2008). Cost analysis of therapy for patients with multiple sclerosis (MS) in Poland.. Pharmacological Reports, 60(5), 632-644. https://europub.co.uk/articles/-A-134071